Omega Pharma Australia
Whoa! How did you get here? This company profile is not meant to be publicly available. Research on this company is incomplete, and the overall rating has been disabled, but while you are here feel free to have a look at the info we do have.
OVERALL |
|
Owned |
IRL |
Rating |
N/A |
Pharmaceuticals wholesaler
Company Ownership
Aurora Pharmaceuticals Pty Ltd | AUS | website | ||||
Omega Pharma NV ![]() owns 100% of Aurora Pharmaceuticals Pty Ltd |
BEL | website | ||||
Pharmaceuticals Omega Pharma's products are sold in about 40 countries. CEO Marc Coucke co-founded the company in 1987. Acquired by Perrigo in 2015. | ||||||
Perrigo Company plc ![]() owns 100% of Omega Pharma NV |
IRL | website | ||||
Healthcare products One of the world's largest manufacturers of generic and private-label OTC (over-the-counter) pharmaceuticals and supplements. When Perrigo bought Elan Corporation in 2013, it moved its headquarters to Ireland to reduce its corporate tax rate. |
Company Assessment
PRAISE | CRITICISM | INFORMATION | ||
Aurora Pharmaceuticals Pty Ltd | ||||
In 2014, 2013, 2011 and 2010 the Therapeutic Goods Administration's Complaints Resolution Panel upheld complaints about six ads by this company on the grounds that they breached advertising codes. The Panel requested this company withdraw the ads and not to use representations in the ads again.
Source: TGA Complaints Register (2014) |
||||
Omega Pharma NV | ||||
No assessment data currently available for Omega Pharma NV | ||||
Perrigo Company plc | ||||
JUST Capital polls Americans every year to identify the issues that matter most in defining just business behaviour. For their 2022 rankings the public identified 19 issues, which are organised under the headings Workers, Communities, Customers, Shareholders and Environment. JUST Capital then define metrics that map to those issues and track and analyse the largest, publicly traded U.S. companies. This analysis powers their rankings, in which this company ranked 635th of 954 companies, and 35th of 46 Pharmaceuticals & Biotech companies.
Source: JUST Capital (2022) |
In 2015 Perrigo agreed to set up a US$2.8 million settlement fund following a class action lawsuit. Plaintiffs alleged that this company's products containing glucosamine and/or chondroitin were represented as formulated to help "rebuild cartilage," "lubricate joints," and "improve joint comfort" when they do not provide these benefits.
Source: Top Class Actions (2015)
In 2019 the median pay for a worker at this company was US$82,616. The CEO was paid 127 times this amount. Exorbitant CEO pay is a major contributor to rising inequality. CEOs are getting more because of their power to set pay, not because they are increasing productivity or possess specific, high-demand skills. The economy would suffer no harm if CEOs were paid less (or taxed more). In contrast, the CEO-to-typical-worker compensation ratio was 20-to-1 in 1965 and 58-to-1 in 1989.
Source: AFL-CIO (2020)
This company has Corporate Responsibility claims on its website in the areas of environmental stewardship, worker safety, packaging and community partnerships.
Source: company website (2014)
This company is a member of How2Recycle. The How2Recycle Label is a voluntary, standardized labeling system that clearly communicates recycling instructions to the public. It involves a coalition of forward thinking brands who want their packaging to be recycled and are empowering consumers through smart packaging labels. Companies must be a member of the program to use the How2Recycle Label.
Source: How2Recycle (2020)
In 2021, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of C.
Source: CDP (2021)
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
Source: Modern Slavery Registry (2018)
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
Source: Open Secrets (2020)
This company received an S&P Global ESG Score of 41/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 7 Feb 2021). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2021) |
Company Details
Type | Wholly-owned subsidiary |
Contact Details
Address | Level 2, 7 Narabang Way, Belrose, NSW, 2085, Australia |
Phone | 02 9847 7999 |
Freecall | 1300 765 805 |
customer.service@omegapharma.com.au | |
Website | www.omegapharma.com.au |